Related Experiment Video
Updated: Sep 28, 2025
Orthotopic Implantation and Peripheral Immune Cell Monitoring in the II-45 Syngeneic Rat Mesothelioma Model
Published on: October 2, 2015
Biphasic Peritoneal Mesothelioma: A Lethal Clinical Entity
Abdul Waheed1, Shahin Foroutan2, Audrey McCloskey3
1Surgery, San Jaoquin General Hospital, San Jaoquin, USA.
Abstract:
Mesotheliomas are a rare malignancy of the serosal membrane. Mainly it affects the pleural surfaces followed by the second most common location, "peritoneum." The disease follows an aggressive pattern of spread, and by the time the diagnosis is established, the condition significantly spreads to distant locations. Diagnosis of malignant peritoneal mesothelioma is typically made by tissue biopsy. The standard treatment is radical resection; however, patients have benefited from several other modalities. The current case report describes a unique case of malignant mesothelioma, biphasic peritoneal mesothelioma (BPM), which comprises less than 25% of all peritoneal mesotheliomas. The diagnosis and treatment do not differ from other subtypes; however, the prognosis is poor, and if untreated, the survival is typically less than six months.
Insights
Malignant peritoneal mesothelioma (MPM) is a rare, aggressive cancer. This case report highlights biphasic peritoneal mesothelioma (BPM), a subtype with a poor prognosis, emphasizing the need for timely diagnosis and treatment.
Area of Science:
- Oncology
- Pathology
Background:
- Mesotheliomas are rare malignancies originating from the serosal membrane, predominantly affecting the pleura and peritoneum.
- Malignant peritoneal mesothelioma (MPM) is characterized by aggressive local spread and potential distant metastasis at diagnosis.
Observation:
- Diagnosis of MPM typically relies on tissue biopsy.
- This case report details a unique instance of biphasic peritoneal mesothelioma (BPM), a rare subtype constituting less than 25% of all peritoneal mesotheliomas.
Findings:
- Diagnostic and therapeutic approaches for BPM are consistent with other MPM subtypes.
- BPM presents a poor prognosis, with untreated survival typically under six months.
Implications:
- Early detection and comprehensive treatment strategies are crucial for improving outcomes in MPM, particularly rare subtypes like BPM.
- Further research into the specific characteristics and treatment sensitivities of biphasic peritoneal mesothelioma may offer avenues for improved patient survival.
Related Concept Videos
01:30Pleural Disorders: Types and Brief Description
02:30Metastasis
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...